Skip to main content
LAMEDITECH Co., Ltd. logo

LAMEDITECH Co., Ltd. — Investor Relations & Filings

Ticker · 462510 ISIN · KR7462510009 KO Manufacturing
Open in API
Filings indexed 52 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 462510

About LAMEDITECH Co., Ltd.

https://m.en.lameditech.com/dh/about1.h…

LAMEDITECH Co., Ltd. is a company that develops and manufactures medical and beauty devices based on laser technology. The company specializes in laser miniaturization technology. Its main products include laser blood samplers, also known as laser lancing devices, and other laser-based medical equipment. The company's founding philosophy is based on confidence, challenge, and customer satisfaction, with a mission to become a global leader in healthcare focused on laser technology. LAMEDITECH markets its products internationally, with a presence in markets such as the United States, Japan, and the European Union.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 99% confidence The document is titled “분기보고서 (제15기)” covering the period January 1, 2026 to March 31, 2026. It is a full, substantive quarterly report (분기보고서) submitted to the Financial Services Commission and Korea Exchange, containing detailed company overview, business content, actual financial statements, notes, management analysis, and auditor’s opinion. This aligns with our definition of an Interim / Quarterly Report (IR), not merely an announcement of a report. Therefore, the correct classification is IR. Q1 2026
2026-05-15 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 90% confidence The document is a formal regulatory filing notifying the Financial Services Commission/Korea Exchange of appointments and resignals of outside directors. It details changes in board composition (number of outside directors before/after, term dates, biographical info). This matches the "Board/Management Information" category rather than an AGM material, earnings release, proxy, or insider transaction. Therefore, the correct classification is MANG (Board/Management Information).
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the official announcement of the results of the 2026 annual general shareholders’ meeting (정기주주총회 결과), detailing each resolution item, voting outcomes, and related meeting information. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-03-26 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the 14th fiscal year (2025), covering company overview, business activities, financial statements, management discussion and analysis, and governance details. It is a formal, long-form regulatory filing submitted to the Financial Supervisory Service and Korea Exchange. Given its structure and content, it aligns with the definition of an Annual Report (10-K). FY 2025
2026-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from a Korean company (Lameditech) titled 'Audit Report Submission'. It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, profit/loss), and auditor information. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and filing of the audit report, rather than the full audit report document itself. According to the 'Menu vs Meal' rule, this is a formal announcement of the report's availability and key findings, fitting the definition of a Report Publication Announcement (RPA). FY 2025
2026-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Lameditech. It contains the agenda for the meeting, including financial statement approval, director re-elections, and proposed amendments to the articles of incorporation. This document is a formal proxy statement/notice sent to shareholders to inform them of the upcoming meeting and solicit their participation/votes. In the context of the provided filing categories, this aligns with 'Proxy Solicitation & Information Statement'.
2026-03-10 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.